This test is most useful if any of these apply to you.
Your gut is home to trillions of microbes, and what matters most is not only which ones live there but what they actually make. This panel skips the census and reads the output: the bile acids and fatty acids your bacteria produce as they process your food and your own digestive fluids.
That output is a functional snapshot of how your microbial community is working. Standard microbiome tests tell you who is present. This one estimates what they are doing, though the frameworks for interpreting the numbers are still taking shape.
The panel tells two intertwined stories. The first is about bile acids, the fat-digesting compounds your liver makes and releases into your gut. Bacteria reshape them in a two-step relay: first they snip off a chemical tag (deconjugation), then a smaller group of specialist microbes converts these liver-made "primary" bile acids into "secondary" bile acids like deoxycholic acid and lithocholic acid. In healthy people, secondary forms usually make up most of the stool bile acid pool.
When that conversion falters, the balance tips toward primary bile acids and away from secondary ones. A low secondary-to-primary balance has been reported in conditions from bile acid diarrhea to cirrhosis, where stool showed the lowest secondary bile acids and the highest primary ones. In research on diarrhea-predominant irritable bowel syndrome (a common gut disorder, often shortened to IBS), stool cholic acid and chenodeoxycholic acid ran markedly high while lithocholic acid and ursodeoxycholic acid ran low.
The second story is about fermentation. When your microbes ferment dietary fiber, they release short-chain fatty acids (the fuel-like chemicals that feed your colon lining and calm inflammation, often abbreviated SCFAs). Butyrate is the standout: it is the preferred fuel of the cells lining your colon. Lower stool SCFAs show up repeatedly in inflammatory bowel disease (chronic gut inflammation, abbreviated IBD) and colorectal cancer (abbreviated CRC). One pooled analysis found lower stool butyrate in people with colorectal cancer than in healthy people, and separately, when several short-chain fatty acids were combined, lower overall levels tracked with higher cancer occurrence, with a pooled standardized difference of 0.45 (95% CI 0.19 to 0.72).
A third set of markers reads protein fermentation. When microbes run low on fiber and lean on protein instead, they make branched-chain fatty acids like isobutyrate and isovalerate. Measuring these alongside the fiber-derived acids shows whether your microbiome is tilting toward fiber or toward protein as its main fuel, a distinction neither bile acids nor total fatty acids can reveal alone.
The value of this panel is in the combinations. Bile acids read out how your microbes transform your own compounds, while the fatty acids read out how they ferment your diet. Reading both at once shows whether a shift is confined to one pathway or reflects a broader change in the community.
| Pattern | What it may suggest |
|---|---|
| High primary bile acids, low secondary bile acids | Your microbes are converting less bile than usual, seen in bile acid diarrhea and some inflammatory states |
| Low butyrate and other fiber-derived fatty acids | Less fiber fermentation and less fuel reaching the colon lining |
| High branched-chain fatty acids | More protein fermentation, often alongside lower fiber intake |
| Low secondary bile acids plus low butyrate together | A broad move away from a fiber-fed, balanced microbial community |
This panel is used mainly in research and functional-medicine settings, and standardized clinical cutoffs for it do not yet exist. Treat the results as a starting point for conversation, not a diagnosis. If your primary bile acids run high with watery stools, bile acid diarrhea is worth raising with a clinician. If butyrate and other fiber-derived acids run low, added dietary fiber is the most direct lever, and a repeat test can show whether the change moved the numbers.
Pair the panel with markers that measure different things: a stool inflammation marker such as calprotectin, a digestion marker such as pancreatic elastase, and a stool blood test if colorectal cancer screening is due. Because a single stool sample is a weak proxy for your usual state, serial testing is more informative than a one-off. Retesting a few months after a meaningful diet change, and again to confirm a trend, gives a clearer read than any single result.
Several factors move many of these markers at once. What you ate in the days before collection shifts both fatty acids and some bile acids. How fast stool moves through you changes concentrations independent of what your microbes are producing. Medications, including antibiotics and some diabetes drugs, alter bile acid and microbial activity.
The measurement itself is reliable, but the biology is not steady. Lab reproducibility for these assays is high, yet the same person's values over six months are often quite variable. That is why a lone abnormal value is best read as a prompt to look closer, ideally with a repeat sample, rather than as a fixed fact about your gut.
StoolOMX™ is best interpreted alongside these tests.